Key points are not available for this paper at this time.
The writing committee presents updated best practice guidelines for the clinical management of congenital adrenal hyperplasia based on published evidence and expert opinion with added considerations for patient safety, quality of life, cost, and utilization.
Speiser et al. (Wed,) studied this question.